Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
Vicente Neto from Bradesco issued a price target of $19.00 for PBR on 2026-04-16 00:16:57.The adjusted price target was set to $19.00.At the time of the announcement, PBR...
April 15, 2026 PBR -2.24%
Angel Castillo from Morgan Stanley issued a price target of $139.00 for CRH on 2026-04-15 12:30:07.The adjusted price target was set to $139.00.At the time of the announcement,
April 15, 2026 CRH -1.02%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| IMMP Immutep Limited | 0.54
72.81% | ||||||||||||||||||
| SLN Silence Therapeutics plc | 7.28
18.95% | ||||||||||||||||||
| MRM MEDIROM Healthcare Techno | 1.26
13.51% | ||||||||||||||||||
| ALAR Alarum Technologies Ltd. | 7.00
10.58% | ||||||||||||||||||
| LEGN Legend Biotech Corporatio | 20.52
9.79% | ||||||||||||||||||
| SOS SOS Limited | 1.15
9.52% | ||||||||||||||||||
| NVX Novonix Limited | 0.80
9.25% | ||||||||||||||||||
| LITB LightInTheBox Holding Co. | 2.60
9.24% | ||||||||||||||||||
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT 1.30%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA -0.50%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 CUK 0.70%